Voir la source de 7 Astonishing Pieces Of Information Concerning Thalidomide

? 2012 Wiley Periodicals, Inc. ""The purpose of this study was to establish whether an increase in failed termination of pregnancy is observed among individuals with arthrogryposis (multiple congenital contractures). A total of 2,500 unselected patients with arthrogryposis collected by the author over a 35-year period were reviewed. The cases included referrals, consultations, personal examinations, and correspondence. They were reviewed for clinical features, pregnancy complications, family history, and a history of attempted terminations of the pregnancy. Eleven cases of failed terminations of pregnancy in which the individuals were subsequently born with arthrogryposis were identified. We conclude that infants who survive attempted termination of pregnancy (both surgical and medical) may be at an increased risk to be born with multiple congenital [http://www.selleckchem.com/products/lee011.html Ribociclib] [http://en.wikipedia.org/wiki/Thalidomide Thalidomide] contractures. Careful examination of the tissue and a post-procedure ultrasound will help to assure that the termination has been successful. Those infants surviving attempted termination of pregnancy who have arthrogryposis are also at >50% risk for intellectual disability. ? 2012 Wiley Periodicals, Inc. ""We report on two patients with 1.7 and 1.2?Mb terminal 20p deletions, which have apparently not been reported previously. Both individuals exhibit certain similar features including large fontanelles, ear abnormalities, and seizures. However, even though the deletions are of similar size, there were many disparate features between the two. The deletions in each patient encompass at least 28 genes that may provide useful candidates for ear development and cranial ossification. ? 2010 Wiley-Liss, Inc. ""As the resolution of molecular cytogenetic methods continues to improve, it has become increasingly possible to refine genotype�Cphenotype correlations based upon gene involvement. We report three new patients with nonrecurrent deletions involving [http://www.selleckchem.com/products/pd-1-pd-l1-inhibitor-2.html Selleckchem PD-1/PD-L1 inhibitor 2] subbands of 2q24. These patients were referred for evaluation of developmental delay, but were found to have unique, nonoverlapping clinical features. Patient 1 presented with infantile seizures, microcephaly, and brain anomalies, along with facial dysmorphism, growth retardation, neuromuscular scoliosis, and later with developmental regression. Array comparative genomic hybridization (aCGH) detected an 8?Mb interstitial deletion encompassing the neuronal sodium channel (SCN) gene cluster. Patient 2 presented with growth retardation, congenital heart defect, and hypotonia. Patient 3 presented with developmental delay and behavioral problems. Patients 2 and 3 had no history of seizures, microcephaly, or brain anomalies and were found to have deletions of 2q24, ?8?Mb and